Fig. 1A—34-year-old woman with orbital venous malformation in right
inferior orbit (patient 2 in Table
1). Photograph taken before procedure shows proptosis, swelling of
lower lid, restricted motility, and dysraphism.
Fig. 1B—34-year-old woman with orbital venous malformation in right
inferior orbit (patient 2 in Table
1). Photograph taken 5 days after procedure shows orbital swelling
at its peak.
Fig. 1C—34-year-old woman with orbital venous malformation in right
inferior orbit (patient 2 in Table
1). Photograph taken 3 months after procedure shows proptosis and
orbital swelling have decreased dramatically.
Fig. 2A—26-year-old woman with left orbital venous malformation
(patient 15 in Table 1).
Percutaneous puncture of lesion under fluoroscopic guidance. Venous
malformation (arrowheads) is filled with nonionic contrast material
(black arrows) in medial left orbit and drainage is shown. White
arrow = puncture needle.
Fig. 2B—26-year-old woman with left orbital venous malformation
(patient 15 in Table 1). Five
minutes after procedure, pingyangmycin Lipiodol emulsion (black
arrows) has distributed well in lesions. White arrow = puncture
needle.
Fig. 3A—17-year-old boy with orbital venous malformation who had
proptosis (approximately 7 mm) (patient 5 in
Table 1). CT scan obtained
before sclerotherapy shows mass in right orbit.
Fig. 3B—17-year-old boy with orbital venous malformation who had
proptosis (approximately 7 mm) (patient 5 in
Table 1). Nine months after
sclerotherapy, CT scan shows proptosis has disappeared and there are few
pingyangmycin Lipiodol emulsion deposits in lesion.